Year |
Citation |
Score |
2021 |
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Begun J, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280 |
0.614 |
|
2020 |
Aysha AA, Rentsch C, Prentice R, Johnson D, Bryant RV, Ward MG, Costello SP, Lewindon P, Ghaly S, Connor SJ, Begun J, Christensen B. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty. Internal Medicine Journal. 50: 798-804. PMID 32656985 DOI: 10.1111/Imj.14889 |
0.324 |
|
2020 |
Pulley J, Todd A, Flatley C, Begun J. Malnutrition and quality of life among adult inflammatory bowel disease patients. Jgh Open : An Open Access Journal of Gastroenterology and Hepatology. 4: 454-460. PMID 32514453 DOI: 10.1002/Jgh3.12278 |
0.306 |
|
2020 |
Rajagopalan A, Sathananthan D, An YK, Van De Ven L, Martin S, Fon J, Costello SP, Begun J, Bryant RV. Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledge. Jgh Open : An Open Access Journal of Gastroenterology and Hepatology. 4: 267-272. PMID 32280776 DOI: 10.1002/Jgh3.12268 |
0.321 |
|
2020 |
Giri R, Shamsunnahar K, Salim A, Capon R, Morrison M, O Cuiv P, Begun J. OP36 Investigating the role of bioactives produced by gut bacteria to modulate immune response in inflammatory bowel disease Journal of Crohn's and Colitis. 14: S037-S038. DOI: 10.1093/Ecco-Jcc/Jjz203.035 |
0.381 |
|
2020 |
Reed H, Begun J. The future of faecal microbiota transplantation in gastrointestinal illness Microbiology Australia. 41: 70-74. DOI: 10.1071/Ma20027 |
0.354 |
|
2020 |
Giri R, Hoedt EC, Khushi S, Salim A, Capon R, Morrison M, Cuiv PO, Begun J. Tu1302 INVESTIGATING THE ROLE OF BIOACTIVES PRODUCED BY GUT BACTERIA TO MODULATE IMMUNE RESPONSE IN IBD Gastroenterology. 158. DOI: 10.1016/S0016-5085(20)33310-2 |
0.336 |
|
2019 |
An YK, Prince D, Gardiner F, Neeman T, Linedale EC, Andrews JM, Connor S, Begun J. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis. The Medical Journal of Australia. PMID 31680263 DOI: 10.5694/Mja2.50384 |
0.316 |
|
2019 |
Khor B, Conway KL, Omar AS, Biton M, Haber AL, Rogel N, Baxt LA, Begun J, Kuballa P, Gagnon JD, Lassen KG, Regev A, Xavier RJ. Distinct Tissue-Specific Roles for the Disease-Associated Autophagy Genes ATG16L2 and ATG16L1. Journal of Immunology (Baltimore, Md. : 1950). PMID 31451676 DOI: 10.4049/Jimmunol.1800419 |
0.345 |
|
2019 |
Giri R, Cuiv PO, Begun J. Mo1930 – Harnessing Anti-Inflammatory Gut Bioactives to Modulate the Immune Response in Ibd Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)39197-8 |
0.311 |
|
2018 |
Begun J. Predictors in inflammatory bowel disease: Looking into the magic ball: Session one summary. Journal of Gastroenterology and Hepatology. 33: 4. PMID 30187557 DOI: 10.1111/Jgh.14415 |
0.317 |
|
2018 |
Begun J. Selectively targeting the gut in inflammatory bowel disease: Session four summary. Journal of Gastroenterology and Hepatology. 33: 25. PMID 30187550 DOI: 10.1111/Jgh.14430 |
0.319 |
|
2018 |
Ó Cuív P, Giri R, Hoedt EC, McGuckin MA, Begun J, Morrison M. AHG0090 is a Genetically Tractable Bacterium and Produces a Secreted Peptidic Bioactive that Suppresses Nuclear Factor Kappa B Activation in Human Gut Epithelial Cells. Frontiers in Immunology. 9: 790. PMID 29720977 DOI: 10.3389/Fimmu.2018.00790 |
0.307 |
|
2018 |
Bryant RV, Friedman A, Wright EK, Taylor K, Begun J, Maconi G, Maaser C, Novak KL, Kucharzik T, Atkinson NSS, Asthana A, Gibson PR. Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut. PMID 29437914 DOI: 10.1136/Gutjnl-2017-315655 |
0.323 |
|
2018 |
Giri R, Cuiv PO, Begun J. Tu1852 - Role of Anti-Inflammatory Gut Bioactives in the Modulation of Immune Response in Crohn's Disease Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)33478-4 |
0.348 |
|
2018 |
Krishnaprasad K, Walsh A, Begun J, Bell S, Carter D, Grafton R, Sechi A, Sewell K, McMahon A, Connor SJ, Radford-Smith GL, Andrews JM. Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD) Gastroenterology. 154: S-892. DOI: 10.1016/S0016-5085(18)33012-9 |
0.305 |
|
2018 |
Luong D, Begun J. Sa1828 - Enteropathogens Detected on Stool Culture and Multiplex PCR are a Common Finding in Inflammatory Bowel Disease Patients Gastroenterology. 154: S-410-S-411. DOI: 10.1016/S0016-5085(18)31651-2 |
0.301 |
|
2017 |
Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, Barclay M, Begun J, Bryant R, Chan W, Corte C, Ghaly S, Lemberg DA, Kariyawasam V, Lewindon P, et al. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics. PMID 29027257 DOI: 10.1111/Apt.14368 |
0.308 |
|
2017 |
Florin T, Movva R, Begun J, Duley J, Oancea I, O Cuiv P. Colonic thioguanine pro-drug: investigation of microbiome and novel host metabolism. Gut Microbes. 0. PMID 28976243 DOI: 10.1080/19490976.2017.1387343 |
0.322 |
|
2017 |
Ó Cuív P, de Wouters T, Giri R, Mondot S, Smith WJ, Blottière HM, Begun J, Morrison M. The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner. Anaerobe. PMID 28583864 DOI: 10.1016/J.Anaerobe.2017.06.002 |
0.301 |
|
2016 |
Elshaer D, Begun J. The role of barrier function, autophagy, and cytokines in maintaining intestinal homeostasis. Seminars in Cell & Developmental Biology. PMID 27565684 DOI: 10.1016/J.Semcdb.2016.08.018 |
0.393 |
|
2016 |
Oancea I, Movva R, Das I, Aguirre de Cárcer D, Schreiber V, Yang Y, Purdon A, Harrington B, Proctor M, Wang R, Sheng Y, Lobb M, Lourie R, Ó Cuív P, Duley JA, ... Begun J, et al. Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism. Gut. PMID 27411368 DOI: 10.1136/Gutjnl-2015-310874 |
0.317 |
|
2016 |
Lassen KG, McKenzie CI, Mari M, Murano T, Begun J, Baxt LA, Goel G, Villablanca EJ, Kuo SY, Huang H, Macia L, Bhan AK, Batten M, Daly MJ, Reggiori F, et al. Genetic Coding Variant in GPR65 Alters Lysosomal pH and Links Lysosomal Dysfunction with Colitis Risk. Immunity. PMID 27287411 DOI: 10.1016/J.Immuni.2016.05.007 |
0.358 |
|
2016 |
Ó Cuív P, Begun J, Keely S, Lewindon PJ, Morrison M. Towards an integrated understanding of the therapeutic utility of exclusive enteral nutrition in the treatment of Crohn's disease. Food & Function. PMID 26948398 DOI: 10.1039/C5Fo01196E |
0.314 |
|
2015 |
Begun J, Lassen KG, Jijon HB, Baxt LA, Goel G, Heath RJ, Ng A, Tam JM, Kuo SY, Villablanca EJ, Fagbami L, Oosting M, Kumar V, Schenone M, Carr SA, et al. Integrated Genomics of Crohn's Disease Risk Variant Identifies a Role for CLEC12A in Antibacterial Autophagy. Cell Reports. 11: 1905-18. PMID 26095365 DOI: 10.1016/J.Celrep.2015.05.045 |
0.351 |
|
2012 |
Huett A, Heath RJ, Begun J, Sassi SO, Baxt LA, Vyas JM, Goldberg MB, Xavier RJ. The LRR and RING domain protein LRSAM1 is an E3 ligase crucial for ubiquitin-dependent autophagy of intracellular Salmonella Typhimurium. Cell Host & Microbe. 12: 778-90. PMID 23245322 DOI: 10.1016/J.Chom.2012.10.019 |
0.357 |
|
2008 |
Miyata S, Begun J, Troemel ER, Ausubel FM. DAF-16-dependent suppression of immunity during reproduction in Caenorhabditis elegans. Genetics. 178: 903-18. PMID 18245330 DOI: 10.1534/Genetics.107.083923 |
0.555 |
|
2007 |
Begun J, Gaiani JM, Rohde H, Mack D, Calderwood SB, Ausubel FM, Sifri CD. Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. Plos Pathogens. 3: e57. PMID 17447841 DOI: 10.1371/Journal.Ppat.0030057 |
0.575 |
|
2005 |
Sifri CD, Begun J, Ausubel FM. The worm has turned--microbial virulence modeled in Caenorhabditis elegans. Trends in Microbiology. 13: 119-27. PMID 15737730 DOI: 10.1016/J.Tim.2005.01.003 |
0.556 |
|
2005 |
Begun J, Sifri CD, Goldman S, Calderwood SB, Ausubel FM. Staphylococcus aureus virulence factors identified by using a high-throughput Caenorhabditis elegans-killing model. Infection and Immunity. 73: 872-7. PMID 15664928 DOI: 10.1128/Iai.73.2.872-877.2005 |
0.517 |
|
2004 |
Bolm M, Chhatwal GS, Jansen WTM, Ausubel FM, Begun J, Kim DH, Moy T, Ruvkun G, Calderwood SB, Sifri CD, Garsin DA. Bacterial Resistance of daf-2 Mutants [2] (multiple letters) Science. 303: 1976. PMID 15044786 |
0.6 |
|
2003 |
Garsin DA, Villanueva JM, Begun J, Kim DH, Sifri CD, Calderwood SB, Ruvkun G, Ausubel FM. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science (New York, N.Y.). 300: 1921. PMID 12817143 DOI: 10.1126/Science.1080147 |
0.691 |
|
2003 |
Sifri CD, Begun J, Ausubel FM, Calderwood SB. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infection and Immunity. 71: 2208-17. PMID 12654843 DOI: 10.1128/Iai.71.4.2208-2217.2003 |
0.564 |
|
Show low-probability matches. |